Previous 10 | Next 10 |
GAITHERSBURG, Md., April 26, 2023 (GLOBE NEWSWIRE) -- NexImmune, Inc. (Nasdaq: NEXI), a biotechnology company developing a novel approach to immunotherapy designed to orchestrate a targeted immune response by directing the function of antigen-specific T cells for liquid and solid malignancies, to...
2023-03-28 17:06:22 ET Neximmune press release ( NASDAQ: NEXI ): Q4 GAAP EPS of -$2.60. Cash, cash equivalents and marketable securities for the Company as of December 31, 2022 were $34.6 million For further details see: Neximmune GAAP EPS of -$2.60
Company has initiated pre-IND discussions with the FDA for its first AIM INJ indication NEXI-001 completed enrollment in its final safety cohorts and all patients have been dosed; Company continues to follow patients and will announce data at or around an upcoming scientific conference ...
3 Ways to Identify Penny Stock Trends Penny stocks can offer significant upside potential for investors who are willing to take on some risk. However, penny stocks can also be highly volatile, which makes it challenging to identify trends and make informed investment decisions. For this r...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: MagioreStock / Shutterstock.com Wix (NASDAQ: WIX ) layoffs are on the way as the Israeli software company reveals another batch of job cuts . The newest Wix layoffs have the company cutting 370 jobs out o...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: CI Photos / Shutterstock.com NexImmune (NASDAQ: NEXI ) stock is rocketing higher on Thursday following the release of positive preclinical trial data . According to a press release from the company, precl...
NexImmune ( NASDAQ: NEXI ) stock rose ~55% premarket on Thursday after the company said that new positive, preclinical data showed that AIM ACT T cells enhance the response to bispecific T cell engager therapy. The data in the abstract titled, 'Prior Antigen Exposure Enhances the ...
Tumor Associated Antigen (TAA)-specific AIM ACT CD8 T cells are superior to polyclonal peripheral blood CD4 T cells, naïve CD8 T cells, and bulk CD8 T cells as effectors of BiTE-mediated killing in vivo GAITHERSBURG, Md., Feb. 16, 2023 (GLOBE NEWSWIRE) -- NexImmune, Inc. (Nasdaq...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: photobyphm / Shutterstock.com WeWork (NYSE: WE ) layoffs are on the way as the company reveals job cuts as it prepares to release its latest earnings report. According to a press release from WeWork, the...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: Bukhta Yurii / Shutterstock.com NexImmune (NASDAQ: NEXI ) stock is falling on Friday as the immunotherapies company’s shares come off of a recent high earlier this week. The NEXI stock rally started...
News, Short Squeeze, Breakout and More Instantly...
A look at the top 10 most actives in the United States Serve Robotics Inc. (SERV) rose 187.1% to $7.55 on volume of 255,453,115 shares 60 Degrees Pharmaceuticals Inc. (SXTP) rose 10.2% to $0.271 on volume of 224,640,171 shares NVIDIA Corporation (NVDA) fell 2.6% to $117.93 on volume of 21...
A look at the top 10 most actives in the United States 60 Degrees Pharmaceuticals Inc. (SXTP) rose 98.3% to $0.4878 on volume of 116,444,604 shares NVIDIA Corporation (NVDA) fell 0.2% to $120.8 on volume of 26,900,560 shares Serve Robotics Inc. (SERV) rose 61.2% to $4.2399 on volume of 25...
A look at the top 10 most actives in the United States Onconetix Inc. (ONCO) rose 46.5% to $0.2183 on volume of 404,016,812 shares NVIDIA Corporation (NVDA) rose 2.6% to $121.09 on volume of 317,123,916 shares PROSHARES TRUST (SQQQ) rose 1.5% to $8.23 on volume of 207,449,647 shares Max...